Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=185"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=185

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT02713594-885852b5",
        "title": "Incentive vs Control: Abstinence From Smoking",
        "summary": "205 of 948 against 131 of 952; risk difference 7.9 points, 95% interval 4.4 to 11.3; NCT02713594, Wisconsin Tobacco Quit Line Medicaid Incentive Evaluation",
        "record": "/library/comparisons/NCT02713594-885852b5",
        "nct_id": "NCT02713594",
        "kind": "outcome",
        "participants": 1900,
        "risk_difference": {
          "value": 0.07863968372158989,
          "lower": 0.0444111915821111,
          "upper": 0.11275708862238404
        },
        "group_1": "205 of 948",
        "group_2": "131 of 952",
        "difference": "7.9 points",
        "interval": "4.4 to 11.3",
        "trial_title": "Wisconsin Tobacco Quit Line Medicaid Incentive Evaluation"
      },
      {
        "id": "NCT06060457-deaths",
        "title": "Fluzone HD + mRNA-1345 Followed by Placebo vs Fluzone HD + Placebo Followed by mRNA-1345: deaths from any cause",
        "summary": "2 of 950 against 2 of 950; risk difference 0.0 points, 95% interval -0.6 to 0.6; NCT06060457, A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age",
        "record": "/library/comparisons/NCT06060457-deaths",
        "nct_id": "NCT06060457",
        "kind": "deaths",
        "participants": 1900,
        "risk_difference": {
          "value": 0,
          "lower": -0.00574498762741302,
          "upper": 0.00574498762741302
        },
        "group_1": "2 of 950",
        "group_2": "2 of 950",
        "difference": "0.0 points",
        "interval": "-0.6 to 0.6",
        "trial_title": "A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=186",
  "request_id": "l1Tc5fzdv1cz63pk"
}